title: How should the applications of genome editing be assessed and regulated?
abstract: An EASAC working group on genome editing recommends that regulators should focus on specific applications of these new techniques rather than attempting to regulate genome editing itself as a new technology.
authors.affiliation: Bioscience Programme at European Academies Science Advisory Council, Halle, Germany.
authors.forename: Robin
authors.identifier: 0000-0003-1603-4806
authors.initials: R
authors.lastname: Fears
authors.affiliation: EASAC Working Group on Genome Editing and is at the German National Academy of Sciences Leopoldina, Halle, Germany.
authors.forename: Volker
authors.initials: V
authors.lastname: Ter Meulen
mesh_terms: D000383:Agriculture / Q000379:methods; D000818:Animals; D005062:European Union; D000072669:Gene Editing / Q000941:ethics* / Q000331:legislation & jurisprudence* / Q000379:methods / Q000592:standards; D006801:Humans
keywords: CRISPR-Cas; EASAC; genome editing; human biology; medicine; regulation; science policy